Mpox drug, tecovirimat, outcomes are similar regardless of HIV status
by Press Release from Outbreak News Today on (#6BHKE)
NewsDesk @bactiman63 Mpox patients treated with tecovirimat, an antiviral drug widely used since last summer's outbreak, had similar outcomes regardless of HIV status, researchers at Columbia University's Vagelos College of Physicians and Surgeons and Weill Cornell Medicine have found. Columbia and Weill Cornell were two of the early sites in New York City to see patients [...]
The post Mpox drug, tecovirimat, outcomes are similar regardless of HIV status appeared first on Outbreak News Today.